Work is continuing so that the drug, and similar medicines, can be issued under medical card schemes to slash costs.

Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

LONDON, March 24 (Reuters) - German software company SAP (SAPG.DE), opens new tab overtook Danish healthcare company Novo Nordisk (NOVOb.CO), opens new tab as Europe's largest company by market ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country that is ...

New York, New York-- (Newsfile Corp. - March 24, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ...

The initiative was piloted at Boots pharmacies last year, but has now been taken to a national level, according to Novo Nordisk. "Up to 85% of the materials in every pen returned to Novo Nordisk ...

Novo Nordisk's hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after a series of trial results sent shares falling. Headline results from a ...

Novo Nordisk Thailand has announced the successful implementation of a blockchain-based traceability solution to verify the authenticity of Ozempic® across the supply chain, addressing the growing ...

It comes in a device like a pen that users inject themselves with on a weekly basis. Manufactured by Danish group Novo Nordisk, it contains the same drug semaglutide as the company’s Ozempic ...